ID
EN
About Us
We are a world-class life science company with global competitiveness that has a role to provide and develop International standard Lifescience Products to Improving the Quality of Life.
Who We Are
Backed by expertise, experience, and a learning process spanning over 130 years, Bio Farma stands as a key player in the effort to save and improve the quality of human life. Given its vital role in advancing the nation’s health, Bio Farma’s presence has been sustained over the years.
Bio Farma is a State-Owned Enterprise (SOE) whose shares are held by 1 (one) Series A Dwiwarna of the Republic of Indonesia and 17,481,278 (seventeen million four hundred eighty-one thousand two hundred seventy-eight) Series B shares of PT Danantara Asset Management (Persero). The Company’s authorized capital is set at Rp61,000,000,000,000.00 (sixty-one trillion Rupiah).
The purpose and objectives of the Company are to conduct business in the fields of manufacturing, trade, professional, scientific, and technical activities, human health activities, financial activities, transportation and trade, information and communication, agriculture, education, accommodation services, real estate, recreation, leasing activities, and other business support services, as well as to optimize the utilization of the Company’s resources to produce high-quality and highly competitive goods and/or services to generate/pursue profits to increase the Company’s value by applying the principles of a Limited Liability Company.
Our History
In its long history, Bio Farma has transformed into a world-class producer of vaccines and antisera. Our story began when the Dutch East Indies administration established the “Parc-vaccinogène (National Institute of Vaccine Development) on August 6, 1890.
6 August 1890
Bio Farma was established under the name of Parc Vaccinogene” on 6 August 1890 based on the Decree of the Governor of the Dutch Indies No. 14 of 1890, in the Weltervreden Military Hospital, Batavia, which now function as the military Hospital (RSPAD) Gatot Soebroto, Jakarta.
1895-1901
The Company’s name was changed to “Parc Vaccinogene en Instituut Pasteur.”
1902 - 1941
The Company changed its name again to “Landskoepoek Inrichting en Instituut Pasteur.” In 1923, Bio Farma was relocated in Jalan Pasteur No. 28 Bandung, and led by L. Otten.
1942 - 1945
During the Japanese occupation, Bio Farma changed its name to “Bandung Boeki Kenkyusho” and was led by Kikuo Kurauchi.
1945 - 1946
The Indonesian name of “Gedung Cacar and Lembaga Pasteur” was attributed to the Company, which was then led by R.M. Sardjito, the first Indonesian officer who led the Company. Under his leadership, the head office was moved to Klaten.
1946 -1949
During the Military Aggression, when Bandung was taken over by the Dutch army, the Company changed its name once more to “Landskoepoek Inrichting en Instituut Pasteur.”
1950 - 1954
The Company changed its name again to “Gedung Cacar and Lembaga Pasteur”, and was one of the institutionsunder the auspices of the Ministry of Health of the of Republic Indonesia.
1955 - 1960
During the nationalization of Dutch companies in Indonesia, the Company later changed its name to “State Company Pasteur”The Company was then more popularly known as PN.Pasteur.
1961 - 1978
Company renamed to “State Bio Farma Company”, or better known as PN. Bio Farma.
1978 - 1996
Based on Government Regulation No. 26/1978, the Company changed i name to Bio Farma public company, better known as Perum Bio Farma
1997
Based on Government Regulation No. 1 1997, the Company name changed to Perum Bio Farma (Persero), known today as PT Bio Farma(Persero). The Company is under own state enterprise
1997 - 2011
Bio Farma succeeded in obtaining WHO Prequalification for 12 types of vaccines, marking WHO’s approval for entering global market.
2008
The launch of a new logo reflected the spirit and optimism towards entry into the world class vaccine industry.
2009
Under the new management team, Bio Farma stepped forward as a worldclass vaccine company with global competitiveness.
2013
The Roadmap towards the Lifescience industry began. Launching of the latest Pentavalent vaccine (Diphtheria, Tetanus, Pertussis, Hepatitis B, HiB) and the launching of a national immunization program.
2014
Enhancement of a new Vision,“To be a World Class Lifescience Company with Global Competitiveness”.
2015
Inauguration of the new Heritage Building and Bio Farma Museum.
2016
Expansion of the National Vaccine Research Forum (NVRF) into the National Life Sciences Research Forum (NLSRF).
2018
Indonesia is officially a Center of Excellence (CoE) of The Organization of Islamic Cooperation (OIC). Bio Farma has prepared several concrete steps as a mechanism for cooperation among OIC members.
2020
The Establishment of State-owned Pharmaceutical Holding. Bio Farma was trusted as the leader of PT Kimia Farma, Tbk, and PT Indofarma, Tbk. The purpose of State-owned pharmaceuticals Holding is to strengthen the self-reliance of the national pharmaceutical industry and also to increase the availability, and affordable, of products by creating joint innovations to provide pharmaceutical products that support the pharmaceutical ecosystem in the future.
Philosophy
Dedicated to Improving Quality of Life
Vision
To Become a World Class Life Science Company with Global Competitiveness
Mission
Provide and Develop Life Science Products of International Standards to Improve the Quality of Life
Corporate Culture
Through the spirit of Indonesia Ministry of State Own Enterprise (SoE) which is implemented in the core values AKHLAK (Trustworthy, Competent, Harmonious, Loyal, Adaptive and Collaborative) Bio Farma has an important role in preventing the spread of infectious diseases at the national and global levels
Amanah
Uphold the trustworthy given.
Competency
Continue to learn and develop capabilities
Harmony
Mutual care and respect to diversity
Loyalty
Dedicated and prioritized the interests of Nation and State.
Adaptive
Keep innovating and be enthusiastic in moving or face change.
Collaborative
Building synergistic collaboration.
Logo Philosophy
Bio Farma is an adaptive company in anticipating business and technology trends in vaccine and antisera development. One form of anticipation is to have a logo which is the Company's identity.
2008 -Now
In 2008, the Bio Farma logo was changed to reflect enthusiasm and optimism towards a world-class vaccine industry.
Bio Farma Logo Philosophy
2008 - Now
-
The logo is an adaptation of the imaging form of "Crystal Protein" and "Glicoprotein". This reflects that Bio Farma is a company in the vaccine and serum sector.
-
Imaging a sparkling illusion. In this case, the starlight is interpreted as the spirit and dynamics of Bio Farma, which has a bright future.
-
The dominant color is green. This dominant green color psychologically implies a hygiene and health value.
-
Orange and yellow colors. The orange and yellow colors in an integrated manner imply a progressive spirit and the courage to innovate to always be at the forefront.
Corporate Identity
Bio Farma's distinctive batik is specially designed by the house of Batik Komar, depicting living things consisting of one or several cell collections as raw material in making vaccines or anti-sera. The design of batik in the form of viruses, bacteria, amoeba, communicates messages about aspects of biodiversity while encapsulating the value of professionalism from a biotechnology and life-science company. Every batik icon has a corporate philosophical value "Dedicated to Improve Quality of Life"
Management Policy System
- High Quality Product
- Environmental Protection
- Enviromental Friendly
- Prevention of Injury and Ill-health
- Global Competitiveness
- Continual Improvement
- Customer Satisfaction
- Good Corporate Governance
- Comply with Regulations and Other Requirements
- Conservation of Energy and Natural Resources
